2026-10-10T01:39:44Z https://api.figshare.com/v2/oai

oai:figshare.com:article/33809300 2026-09-15T17:22:47Z category_146 category_7 category_12 category_19 category_21 category_45 category_64 category_132 category_135 portal_5 item_type_3 month_year_09_2026

<p>MICs, molecular characterization, and corresponding clinical outcomes for baseline key LRT pathogens that were imipenem/REL-susceptible at baseline and became imipenem/REL-nonsusceptible during treatment with IMI/REL.</p> Katherine Young (526710) C. Andrew DeRyke (16327142) David W. Hilbert (16327139) Maria C. Losada (24947714) Jiejun Du (728226) Amanda Paschke (6508913) Luke F. Chen (24947717) Space Science Medicine Cell Biology Pharmacology Biotechnology Sociology Cancer Infectious Diseases Computational Biology pseudomonas aeruginosa </ klebsiella pneumoniae </ intensive care unit associated bacterial pneumonia susceptibility determined per obtained &# 8804 baseline pathogen susceptibility negative baseline pathogen rel ), stratified susceptible baseline pathogens imi 2 treated 3 [− 8 nonsusceptible versus imipenem isolate susceptibility &# 8805 baseline isolates susceptible pathogens resistant pathogens negative isolates sequencing techniques one isolate one gram molecular characterization modified intent day 28 central laboratory cause mortality also assessed adjusted difference 59 gram 48 hours 1 ]) <p>MICs, molecular characterization, and corresponding clinical outcomes for baseline key LRT pathogens that were imipenem/REL-susceptible at baseline and became imipenem/REL-nonsusceptible during treatment with IMI/REL.</p> 2026-09-15T17:22:35Z Dataset Dataset 10.1371/journal.pone.0357288.t003 https://figshare.com/articles/dataset/_p_MICs_molecular_characterization_and_corresponding_clinical_outcomes_for_baseline_key_LRT_pathogens_that_were_imipenem_REL-susceptible_at_baseline_and_became_imipenem_REL-nonsusceptible_during_treatment_with_IMI_REL_p_/33809300 CC BY 4.0